{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-11568"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-11568","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Synthesis and Antibacterial Testing of Novel Thiosulfonate Compounds","abstract":"Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) are increasing concerns in the medical community. In addition to the threat of Staphylococcus aureus, the increase in number and severity of infections caused by other antibiotic-resistant bacteria is problematic to human health, particularly among the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter). The antibiotics like the penicillins and cephalosporins used commonly to treat MRSA, VRSA, and ESKAPE pathogens have continued to decline in the effectiveness. Our laboratory has developed a number of new families of anti-MRSA and anti-VRSA antibacterial compounds. In this thesis, an additional series of compounds called S-alkyl thiosulfonate esters were examined. Twenty-eight S-alkyl thiosulfonates were synthesized, characterized spectroscopically, and twenty-three of those were examined for antibacterial activity against a panel of 6 pathogenic bacteria referred to as ESKAPE pathogens. Two compounds, S-propyl propanethiosulfonate (LB-21) and S-sec-butyl sec-butanethiosulfonate (LB-22) exhibited the highest activity against vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Staphylococcus aureus with an MIC50 value of 4 μg/mL and 2 μg/mL, respectively.","abstract_html":"Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) are increasing concerns in the medical community. In addition to the threat of Staphylococcus aureus, the increase in number and severity of infections caused by other antibiotic-resistant bacteria is problematic to human health, particularly among the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter). The antibiotics like the penicillins and cephalosporins used commonly to treat MRSA, VRSA, and ESKAPE pathogens have continued to decline in the effectiveness. Our laboratory has developed a number of new families of anti-MRSA and anti-VRSA antibacterial compounds. In this thesis, an additional series of compounds called S-alkyl thiosulfonate esters were examined. Twenty-eight S-alkyl thiosulfonates were synthesized, characterized spectroscopically, and twenty-three of those were examined for antibacterial activity against a panel of 6 pathogenic bacteria referred to as ESKAPE pathogens. Two compounds, S-propyl propanethiosulfonate (LB-21) and S-sec-butyl sec-butanethiosulfonate (LB-22) exhibited the highest activity against vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Staphylococcus aureus with an MIC50 value of 4 μg/mL and 2 μg/mL, respectively.","abstract_has_math":false,"creators":["Blume, Lindsay I."],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Edward Turos, Ph.D.","James Leahy, Ph.D.","Kirpal Bisht, Ph.D.","Jill Roberts, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-06-07T07:00:00Z","date_published":"2022-06-07T07:00:00Z","updated_at":"2026-11-19T08:49:16Z","subjects":["antimicrobial resistance","ESKAPE","MRSA","nosocomial","sulfur","Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10281","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10281","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-11568","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Edward Turos, Ph.D.","James Leahy, Ph.D.","Kirpal Bisht, Ph.D.","Jill Roberts, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Blume, Lindsay I."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-06-07T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["antimicrobial resistance","ESKAPE","MRSA","nosocomial","sulfur","Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10281"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) are increasing concerns in the medical community. In addition to the threat of Staphylococcus aureus, the increase in number and severity of infections caused by other antibiotic-resistant bacteria is problematic to human health, particularly among the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter). The antibiotics like the penicillins and cephalosporins used commonly to treat MRSA, VRSA, and ESKAPE pathogens have continued to decline in the effectiveness. Our laboratory has developed a number of new families of anti-MRSA and anti-VRSA antibacterial compounds. In this thesis, an additional series of compounds called S-alkyl thiosulfonate esters were examined. Twenty-eight S-alkyl thiosulfonates were synthesized, characterized spectroscopically, and twenty-three of those were examined for antibacterial activity against a panel of 6 pathogenic bacteria referred to as ESKAPE pathogens. Two compounds, S-propyl propanethiosulfonate (LB-21) and S-sec-butyl sec-butanethiosulfonate (LB-22) exhibited the highest activity against vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Staphylococcus aureus with an MIC50 value of 4 μg/mL and 2 μg/mL, respectively."]},{"key":"dc:title","label":"Title","values":["Synthesis and Antibacterial Testing of Novel Thiosulfonate Compounds"]}]}],"canonical_facts":{"dc:contributor":["Edward Turos, Ph.D.","James Leahy, Ph.D.","Kirpal Bisht, Ph.D.","Jill Roberts, Ph.D."],"dc:creator":["Blume, Lindsay I."],"dc:date":["2022-06-07T07:00:00Z"],"dc:description":["Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) are increasing concerns in the medical community. In addition to the threat of Staphylococcus aureus, the increase in number and severity of infections caused by other antibiotic-resistant bacteria is problematic to human health, particularly among the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter). The antibiotics like the penicillins and cephalosporins used commonly to treat MRSA, VRSA, and ESKAPE pathogens have continued to decline in the effectiveness. Our laboratory has developed a number of new families of anti-MRSA and anti-VRSA antibacterial compounds. In this thesis, an additional series of compounds called S-alkyl thiosulfonate esters were examined. Twenty-eight S-alkyl thiosulfonates were synthesized, characterized spectroscopically, and twenty-three of those were examined for antibacterial activity against a panel of 6 pathogenic bacteria referred to as ESKAPE pathogens. Two compounds, S-propyl propanethiosulfonate (LB-21) and S-sec-butyl sec-butanethiosulfonate (LB-22) exhibited the highest activity against vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Staphylococcus aureus with an MIC50 value of 4 μg/mL and 2 μg/mL, respectively."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10281"],"dc:subject":["antimicrobial resistance","ESKAPE","MRSA","nosocomial","sulfur","Chemistry"],"dc:title":["Synthesis and Antibacterial Testing of Novel Thiosulfonate Compounds"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:49:16Z"}